It’s impossible to get basically anything done before you’ve had your coffee—am I right, friends? But something that’s tough, caffeinated or not, is popping off…
Номе
How allergens trigger itching: Finding points to new targets for allergy drug development
A key step in the immune system’s response to allergens has been uncovered by researchers at Massachusetts General Hospital (MGH). They have shown that a…
Research offers new way to forecast COVID-19 cases, study impact of public health measures
A statistical estimation technique developed by a University of Notre Dame researcher offers public health officials a new way to build short-term forecasts of coronavirus…
Rock Health's COO talks digital health funding, M&As and 'Teladongo'
While the economy has been volatile during the pandemic, digital health companies to strike deals with investors raking in more money than ever before. “We’ve already surpassed…
Your Guide to Getting a COVID-19 Test
THURSDAY, Oct. 29, 2020 — Which type of COVID-19 test is best? There are three types of COVID-19 tests. The molecular test, known as the…
FBI, HHS warn of 'increased and imminent' cyber threat to hospitals
In a joint alert sent Wednesday evening, the Cybersecurity and Infrastructure Security Agency, the Federal Bureau of Investigation and the U.S. Department of Health and…
What November's Capricorn Horoscope Predictions Mean for You
Read what your sign's 2020 horoscope predictions have in store for you or check out the Capricorn personality profile. Welcome to November, Capricorn! The end of October saw…
Looked at myself in the mirror and broke down: Avika Gor on her weight loss journey
Avika Gor looked gorgeous in her post-weight loss pictures, donning a pink and yellow ensemble, which she shared on Instagram You may not be able…
UK under pressure as COVID-19 epidemic doubling every 9 days
The British government is under pressure to develop a national strategy to combat a surge of COVID-19 cases and “rescue Christmas” as scientists warn that…
FDA Approves Expanded Indication for Merck’s Keytruda (pembrolizumab) in Adult Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (cHL)
KENILWORTH, N.J.–(BUSINESS WIRE) October 15, 2020 — Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and…